• 1. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 5. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845

6,6-Dioxo-6λ?-Thiaspiro[2.5]Octane-1-Carboxylic Acid: A Comprehensive Overview

The compound with CAS No. 1250754-10-9, known as 6,6-dioxo-6λ?-thiaspiro[2.5]octane-1-carboxylic acid, is a unique sulfur-containing bicyclic compound that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound is notable for its spirocyclic structure, which consists of a thiane ring fused with a lactone moiety. The presence of the dioxo group and the carboxylic acid functional group makes it a versatile molecule with potential applications in drug design and material science.

Recent studies have highlighted the importance of thiaspiro compounds in medicinal chemistry due to their ability to modulate biological targets such as enzymes and receptors. The spirocyclic architecture of this compound provides a rigid framework that can enhance its binding affinity to specific protein pockets. For instance, researchers have explored the use of 6,6-dioxo-6λ?-thiaspiro[2.5]octane-1-carboxylic acid as a lead compound for developing inhibitors of kinases and proteases, which are key targets in cancer therapy.

The synthesis of 6,6-dioxo-6λ?-thiaspiro[2.5]octane-1-carboxylic acid involves a multi-step process that typically begins with the preparation of a suitable thiol intermediate. The formation of the spirocyclic structure is achieved through an intramolecular cyclization reaction, often facilitated by acidic or basic conditions. The introduction of the dioxo group is crucial for stabilizing the spirocyclic framework and enhancing the compound's chemical reactivity. This synthesis pathway has been optimized in recent years to improve yield and purity, making it more accessible for large-scale production.

In terms of pharmacological activity, 6,6-dioxo-6λ?-thiaspiro[2.5]octane-1-carboxylic acid has shown promising results in preclinical studies. For example, it has demonstrated potent anti-inflammatory properties by inhibiting cyclooxygenase (COX) enzymes, which are involved in the production of prostaglandins. Additionally, this compound has been evaluated for its potential as an antimicrobial agent, with studies indicating moderate activity against Gram-positive bacteria.

The structural uniqueness of 6,6-dioxo-6λ?-thiaspiro[2.5]octane-1-carboxylic acid also makes it an interesting candidate for materials science applications. Its rigid spirocyclic structure could be exploited in the development of advanced polymers or nanomaterials with tailored mechanical properties. Researchers are currently investigating its potential as a building block for self-healing materials and stimuli-responsive systems.

In conclusion, CAS No. 1250754-10-9, or 6,6-dioxo-6λ?-thiaspiro[2.5]octane-1-carboxylic acid, represents a fascinating example of how complex molecular architectures can lead to innovative solutions in various scientific domains. With ongoing research focusing on its synthesis optimization and biological evaluation, this compound holds great promise for future advancements in medicine and materials science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)